EGLN1 and neoplasm: In line with these phenotypic changes, tumor rechallenge experiments demonstrated a better long-term protective effect of PHD2/3 KO OT-1 T cells as compared to control OT-1 T cells (Suppl Fig. 3C) in the MC38-OVA tumor model.